We're living in uncertain times due to the pandemic, and that means more flexible especially when we travel.
One change that may be permanent is that people are more open to unconventional travel opportunities -- as well as challenges -- when they book their vacations.
Airbnb CEO Brian Chesky explained at Skift Global Forum 2021 that before the pandemic, working, living and traveling had to be three separate activities. But with remote work now more accepted, it can be one and the same.
"This revolution really is about flexibility," Chesky said. "Suddenly, you can live anywhere, you can work anywhere."
It also means travelers are moving from being strict and rigid to being more malleable. A recent Expedia survey showed that half of global travel searches this summer were for 21 days or less. Airlines are also more open to giving refunds with cancellations, even for the cheapest tickets. Travelers, especially those looking for high-end luxury vacations, are simultaneously planning trips to ensure they go on one, a phenomenon known as "travel stacking."
https://skift.com/2021/09/15/new-research-5-trends-from-travels-2021-summer-surge/
"Flexibility is going to be huge in terms of how travel companies spur demand and then put consumer confidence back," Ali told Cheddar.
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
